This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. In this comprehensive guide, we’ll explore the intricacies of identifying such drugs and leveraging them for successful in-licensing opportunities.
Analysis of 200,000 groundwater samples reveals major mismatch in California groundwater data To ensure that California’s groundwater is sustainably managed in the future and over the long-term, current state definitions of what constitutes groundwater may need to be revised, according to research published this week in PNAS.
PALO ALTO — Step outside the quiet Stanford Medicine building where geneticist and prominent bigdata expert Mike Snyder has spent years poring over tiny samples of blood, and you can just see the outline of 1701 Page Mill Road, one of the original offices of Theranos. Continue to STAT+ to read the full story…
Licensed Clinical Psychologist, Clinical Director, Virtual Counselor/College Telehealth. The term can be used to describe several different technology-related healthcare applications that includes categories like EHR, mHealth, wearables Telehealth, bigdata, apps, and personalized medicine. Reena Kolar , Ph.D,
These might be licensed drugs that could hold potential for a patent extension, or drugs which failed efficacy trials for an intended indication. In the quest to repurpose a drug for a rare condition, there is a need to look at any and all available data.
Licensed Clinical Psychologist, Clinical Director, Virtual Counselor/College Telehealth. The term can be used to describe several different technology-related healthcare applications that includes categories like EHR, mHealth, wearables Telehealth, bigdata, apps, and personalized medicine. Reena Kolar , Ph.D,
Meanwhile, the search for the ‘right target’ led the company to collaborate with Cancer Research UK and launch the Functional Genomics Centre , a centre of excellence for genetic screening, cancer modelling and bigdata processing aimed at accelerating the discovery of new cancer medicines, including those based on CRISPR technology.
We believe our allogenic CAR-T platform is significantly stronger with chPD1 target licensed from Longwood University. ” Kiromic’s DIAMOND is bigdata science meeting target identification, dramatically compressing man-years and billions of drug development dollars to develop a live drug. “We believe Prof.
Late in 2022, AbbVie partnered with HotSpot Therapeutics and announced an exclusive worldwide collaboration and option to license agreement for their interferon regulatory factor 5 (IRF5) inhibitor program for autoimmune disease treatment. In 2022, the FDA proceeded to grant official licensing for Moderna’s Spikevax COVID-19 vaccine.
New-age technologies such as IoT, bigdata analytics, and 5G, as well as trends such as software-as-a-service (SaaS), cloud licensing, new frameworks of software, and high-speed digital standards, will revolutionise the future of analysis, testing and measurement equipment.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content